Tumors
Showing 1 - 25 of 144
Survivors of Paranasal Sinus, Nasopharyngeal and Skull Base
Recruiting
- Tumors
- Standard of Care
-
Houston, TexasM D Anderson Cancer Center
Feb 8, 2023
Image, Warburg Effect, Tumors Trial in Baltimore (Hyperpolarized 13C-Pyruvate)
Not yet recruiting
- Image
- +2 more
- Hyperpolarized 13C-Pyruvate
-
Baltimore, MarylandUniversity of Maryland Medical Center
Jan 30, 2023
Advanced Malignancy, Advanced Solid Tumors, Cancer Trial in Philadelphia, Greenville, San Antonio (AMG 820)
Completed
- Advanced Malignancy
- +5 more
- AMG 820
-
Philadelphia, Pennsylvania
- +2 more
Jan 18, 2023
Advanced Malignancy, Advanced Solid Tumors, Cancer Trial in United States (AMG 337)
Completed
- Advanced Malignancy
- +5 more
- AMG 337
-
Los Angeles, California
- +7 more
Nov 3, 2022
Tumors Trial in Mannheim (intraoperative radiotherapy)
Completed
- Tumors
- intraoperative radiotherapy
-
Mannheim, GermanyDepartment of Radiotherapy University Hospital Mannheim
Jul 19, 2022
Tumors Trial in Hefei (Proton Therapy System (ProBeam))
Recruiting
- Tumors
- Proton Therapy System (ProBeam)
-
Hefei, Anhui, ChinaAnhui Provincial Hospital
Jul 13, 2022
Tumors, Ovarian Cancer, Breast Cancer Trial in Houston (ZN-c3, Bevacizumab, Pembrolizumab)
Not yet recruiting
- Tumors
- +4 more
- ZN-c3
- +2 more
-
Houston, TexasMD Anderson Cancer Center
Jun 20, 2022
Tumors Trial in Seoul (abemaciclib+paclitaxel)
Active, not recruiting
- Tumors
-
Seoul, Korea, Republic ofSeverance Hospital
May 30, 2022
Exercise, CNS Tumors, Tumors Trial in Houston (Focus Groups, Pilot randomized controlled trial)
Recruiting
- Exercise
- +2 more
- Focus Groups
- Pilot randomized controlled trial
-
Houston, TexasM D Anderson Cancer Center
May 10, 2022
Incurable Platinum Refractory Germ Cell Tumors, Tumors Trial in Indianapolis, New York, Philadelphia (ASP1650)
Completed
- Incurable Platinum Refractory Germ Cell Tumors
- Tumors
-
Indianapolis, Indiana
- +2 more
Nov 30, 2021
Cohort of Tumors With POLE/D1 Mutation
Recruiting
- Tumors
- +2 more
-
Toulouse, FranceCHU -hopital Rangeuil
Oct 22, 2021
Neuroendocrine Tumors, Tumors, Cancer Trial in Madison (TAS-102, Temozolomide, Filgrastim)
Active, not recruiting
- Neuroendocrine Tumors
- +3 more
- TAS-102
- +3 more
-
Madison, WisconsinUniversity of Wisconsin Carbone Cancer Center
Oct 29, 2021
Tumors Trial in Sarasota (Hands-free, user-controlled robotic system intended to assist in the planning and advancement of an
Recruiting
- Tumors
- Hands-free, user-controlled robotic system intended to assist in the planning and advancement of an instrument during CT guided percutaneous procedures. T
-
Sarasota, FloridaSarasota Interventional Radiology
Oct 21, 2021
Cancer, Tumors, Tumor Trial in Netherlands (Panitumumab, Olaparib, Dabrafenib)
Recruiting
- Cancer
- +3 more
- Panitumumab
- +32 more
-
Amersfoort, Utrecht, Netherlands
- +34 more
Oct 26, 2021
Tumors Trial in Mannheim (Hyperthermal treatment)
Completed
- Tumors
- Hyperthermal treatment
-
Mannheim, GermanyDepartment of Radiotherapy University Hospital Mannheim
Sep 28, 2021
Point of Care 3D Ultrasound for Various Applications: A Pilot
Recruiting
- Appendicitis
- +22 more
-
Durham, North CarolinaDuke University Medical Center
Sep 21, 2021
Advanced Malignancy, Advanced Solid Tumors, Cancer Trial in France, Netherlands, United States (AMG 232)
Completed
- Advanced Malignancy
- +7 more
- AMG 232
-
Santa Monica, California
- +13 more
Aug 30, 2021